mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.15 |
0.001 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.14 |
0.002 |